检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈力行 杨春万[1] 桑喜梅[1] 张小乐[1] 骆惠芬[1] 李顺然 Chen Lixing;Yang Chunwan;Sang Ximei;Zhang Xiaole;Luo Huifen;Li Shunran(CCU,Zhaoqing No.1 People's Hospital,Zhaoqing 526000)
机构地区:[1]肇庆市第一人民医院CCU科,肇庆526000
出 处:《数理医药学杂志》2022年第5期714-716,共3页Journal of Mathematical Medicine
摘 要:目的:探讨慢性心功能不全(CHF)应用诺新妥辅助治疗对其心功能的影响。方法:选取某院2018年1月-2021年9月收治的80例CHF患者,按投掷硬币法分为常规治疗组和诺新妥组各40例,常规治疗组给予常规药物治疗,诺新妥组在常规治疗组基础上增加诺新妥治疗,比较两组临床疗效、心功能、血清相关指标及生活质量。结果:诺新妥组总有效率(87.50%)高于常规治疗组(67.50%)(P<0.05);治疗后,诺新妥组MMP-9、sST2、NT-pro BNP水平均低于常规治疗组(P<0.05);诺新妥组LVEDS、LVEDd短于常规治疗组,LVEF、FS高于常规治疗组(P<0.05);诺新妥组ML WHFQ评分低于常规治疗组(P<0.05)。结论:诺新妥辅助治疗可减少CHF患者心肌细胞损伤,改善心功能,提高其生活质量,临床疗效佳。Objective:To investigate the effect of adjuvant therapy with Novoxetone on chronic cardiac insufficiency(CHF)on cardiac function.Methods:A total of 80 CHF patients admitted to a hospital from January 2018 to September 2021 were selected.According to the coin tossing method,they were divided into the routine treatment group(40 cases)and the Nuoxintuo group(40 cases).The routine treatment group was given conventional drug treatment,and the Nuoxintuo group received Nuoxintuo treatment on the basis of the conventional treatment group.The clinical efficacy,cardiac function,serum-related indicators and quality of life were compared between the two groups.Results:The total effective rate in the Nuoxintuo group(87.50%)was higher than that in the routine treatment group(67.50%)(P<0.05).After treatment,the levels of MMP-9,sST2 and NT-pro BNP in the Nuoxintuo group were lower than those in the conventional treatment group(P<0.05).LVEDS and LVEDd in Nuoxintuo group were shorter than those in routine treatment group,LVEF and FS were higher than those in routine treatment group(P<0.05).ML WHFQ score in Nuoxintuo group was lower than that in routine treatment group(P<0.05).Conclusion:Adjuvant therapy with Nuxintuo can reduce myocardial cell damage,improve cardiac function,and improve the quality of life in patients with CHF,with good clinical efficacy.
分 类 号:R541[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.21.33.186